A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EpiCept NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy (DPN)

Trial Profile

A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of EpiCept NP-1 Topical Cream in Patients With Pain From Diabetic Peripheral Neuropathy (DPN)

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2011

At a glance

  • Drugs Amitriptyline/ketamine (Primary)
  • Indications Diabetic neuropathies; Neuropathic pain
  • Focus Therapeutic Use
  • Acronyms Neuracept
  • Most Recent Events

    • 15 Sep 2009 Actual end date (1 Apr 2008) added as reported by ClinicalTrials.gov
    • 15 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 07 Feb 2008 Interim results reported by EpiCept.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top